MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Funding Opportunities: Pioneers, Architects & Consolidators
Funding: Strategic Corporate Investment & Corporate Venture Capital (CVC)
*Portfolio Companies: Eli Lilly
Cerulean Pharmaceuticals
Finance & Acquisition: Cerulean
Parents
Cerulean Pharmaceuticals
Children
2010: Cerulean Grabs $24M Series C for Nano Drugs (2010)
2011: Cerulean Pharma Inc Closes $15 Million Series D (2011)
2014: Brushing Off Clinical Setback, Cerulean Tees Up $75M IPO
2014: Cerulean Limps into Nasdaq Debut With $7 Per Share IPO
Cerulean Pharmaceuticals has closed a $24 million Series C funding
Lilly Ventures, the venture arm of drug giant Eli Lilly (NYSE:LLY), led the third-round financing, which included investments by previous Cerulean backers Bessemer Venture Partners, Lux Capital, Polaris Venture Partners, and Venrock Associates
Jumps
*Key People: Cerulean
Organization & Developments: Cerulean